Bio Green Med Solution, Inc. (BGMSP) Net Income towards Common Stockholders (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$217000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 167.9% year-over-year to -$217000.0; the TTM figure through Mar 2026 stood at -$14.2 million (down 70.46% YoY), while the FY2025 annual figure was -$14.1 million, down 25.69% from the prior year.
• Net Income towards Common Stockholders rose to -$217000.0 in Q1 2026 per BGMSP's latest filing, from -$10.2 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$81000.0 in Q1 2025 and bottomed at -$10.2 million in Q4 2025.
• Historically, Net Income towards Common Stockholders has averaged -$4.1 million across 5 years, with a median of -$4.2 million in 2022.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 878.83% — and 2025, when it soared 97.25%.
• Bio Green Med Solution's Net Income towards Common Stockholders stood at -$7.5 million in 2022, then rose by 28.76% to -$5.3 million in 2023, then surged by 42.64% to -$3.1 million in 2024, then slumped by 233.22% to -$10.2 million in 2025, then jumped by 97.87% to -$217000.0 in 2026.
• Business Quant data shows BGMSP's Net Income towards Common Stockholders at -$217000.0 in Q1 2026, -$10.2 million in Q4 2025, and -$2.5 million in Q3 2025.